Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting...
-
Upload
rosaline-watts -
Category
Documents
-
view
221 -
download
0
Transcript of Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting...
![Page 1: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/1.jpg)
Tackling the Nightmare Bacteria Carbapenem-Resistant Enterobacteriaceae (CRE)—Mandatory
Reporting and Development of the Extensively Drug-Resistant Organism (XDRO) Registry in Illinois
Robynn Cheng Leidig, MPH2012 PHPS Fellow
Office for State, Tribal, Local and Territorial SupportCenters for Disease Control and Prevention
2015 PHAP/PHPS Summer SeminarJune 2, 2015
Centers for Disease Control and Prevention
Office for State, Tribal, Local and Territorial Support
![Page 2: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/2.jpg)
BACKGROUND
![Page 3: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/3.jpg)
What is CRE?CarbapenemResistantEnterobacteriaceae
Deadly infection Few treatment options (if any) Spreading quickly
http://www.cdc.gov/drugresistance/threat-report-2013/
![Page 4: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/4.jpg)
CRE in Illinois
Facility type CRE colonization prevalence
Short stay acute care hospitals (adult ICUs) 3% Long term acute care hospitals (LTACHs) 30%
Few prevalence data existed for hospital non-ICU wards, nursing homes, and regions outside of Chicago
Chicago area facilities (REALM project), 2010-2011
Lin MY et al. CID, 2013
First recognized in Chicago area in December 2007
![Page 5: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/5.jpg)
METHODSXDRO Registry Development
![Page 6: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/6.jpg)
Illinois Department of Public Health (IDPH)
the Extensively Drug-Resistant Organism (XDRO) registry
the Chicago CDC Prevention Epicenter and Medical Research Analytics and Informatics Alliance (MRAIA)
Present…
Amendment to the Control of Communicable Diseases Code (77 Ill. Adm. Code 690) Rules
![Page 7: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/7.jpg)
The XDRO registry addresses2 critical gaps
Gap XDRO registry
1. Need improved inter-facility communication
Allows for CRE information exchange
2. Lack of a surveillance system
Stores CRE surveillance data
![Page 8: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/8.jpg)
CRE identified
XDRO registry
Patient admit (Unknown CRE status)
Isolation Precautions (Y/N)
Report
Query
ProvidersLaboratories
![Page 9: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/9.jpg)
RESULTS
![Page 10: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/10.jpg)
How to report: Extensively Drug-Resistant Organism (XDRO) Registry
Began: November 1, 2013
Required to report: Acute care hospitals Long-term acute care hospitalsLong-term care facilitiesLaboratories
CRE Reporting in Illinois
![Page 11: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/11.jpg)
Apr
May Jun Jul
Aug
Sep
Oct
Nov De
c
Jan
Feb
Mar
ch
April
May
2014
0
20
40
60
80
100
120
Patie
nts (
#)Unique patients reported to XDRO registry
Mandatory reporting
2013
![Page 12: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/12.jpg)
XDRO Registry: aggregate data (Nov 1, 2013 – May 13, 2015)
Number of unique patients since November 1st: 1,725
Number of unique facilities that:
have access to the registry 550
have submitted reports 151
have ever queried 127
Total number of queries that have been made: 2,522
![Page 13: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/13.jpg)
Facilities
Local Health Depts.
Accessing CRE/ XDRO Data
![Page 14: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/14.jpg)
CRE and XDRO education
- 30 stakeholder CRE Taskforce - 6 webinars: 605 people- 2 packets: 470 facilities - 2 websites- 1 Press release
![Page 15: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/15.jpg)
Challenge Steps taken… Ensuring secure access to the XDRO registry
All users must register via IDPH web portal
Coordinating among various agencies and key players
Meetings, phone calls, internal webinars
Developing consistency in facility identifiers
Integrating with existing systems (I-NEDSS)
Meeting both clinical and public health needs
Input from public health and clinical stakeholders
Understanding surveillance criteria & reporting rules
Webinars, educational materials, consultations, registry improvements
![Page 16: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/16.jpg)
Implications
Long-term impact Earlier detection of CRE+ patients Better infection control: 63% (N=203) took ≥1 infection control action as
a result of the webinars/ presentations Reduced spread of CRE in the region?
Source: CDC Vital Signs, March 2013
![Page 17: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/17.jpg)
For more information, please contact CDC’s Office for State, Tribal, Local and Territorial Support
4770 Buford Highway NE, Mailstop E-70, Atlanta, GA 30341Telephone: 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348E-mail: [email protected] Web: http://www.cdc.gov/stltpublichealth
The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
For more information visit: www.xdro.org
Robynn Cheng Leidig, [email protected]
312-814-1631
Centers for Disease Control and Prevention
Office for State, Tribal, Local and Territorial Support
![Page 18: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/18.jpg)
EXTRA SLIDES FOR QUESTIONS
![Page 19: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/19.jpg)
CRE surveillance definition(adapted from CDC CRE toolkit)
Reporting facilities shall report CRE based on laboratory test results:
1. Molecular test (e.g., PCR) specific for carbapenemaseOR
2. Phenotypic test (e.g., Modified Hodge) specific for carbapenemase production
OR3. Susceptibility tests (for E. coli and Klebsiella species only):
non-susceptible to ONE of the carbapenems (doripenem, meropenem, or imipenem) AND resistant to ALL third generation cephalosporins tested (ceftriaxone, cefotaxime, and ceftazidime). Ignore ertapenem.
http://www.cdc.gov/hai/organisms/cre/cre-toolkit
![Page 20: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/20.jpg)
Resistance mechanisms reported to XDRO registry
n=36 n=22n=407
Not reported/ Unknown: 312 (40% of total patients)
KPC NDM Other0%
20%
40%
60%
80%
100%
88%
8%5%
![Page 21: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/21.jpg)
System Maturation
*
![Page 22: Tackling the Nightmare Bacteria Carbapenem- Resistant Enterobacteriaceae (CRE)—Mandatory Reporting and Development of the Extensively Drug- Resistant Organism.](https://reader030.fdocuments.net/reader030/viewer/2022032802/56649e185503460f94b03ee5/html5/thumbnails/22.jpg)
Cluster Detection
• SaTScan: Spacial scanning software
• Arcview GIS: Provides graphical display